Herbs (Global Traditional) · Traditional Chinese Medicine
Kuromoji (Lindera umbellata) (Lindera umbellata)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Kuromoji (Lindera umbellata) is a Japanese aromatic plant containing bioactive compounds like linalool and eucalyptol that demonstrate anti-inflammatory and cytotoxic properties. Research shows it can inhibit inflammatory mediators in laboratory models and induce apoptosis in cancer cell lines through mitochondrial pathway activation.
Kuromoji (Lindera umbellata Thunb.) is a tree native to Japan, belonging to the Lauraceae family, commonly found in regions like Shizuoka and Fukushima Prefectures. The essential oil is extracted via steam distillation from its branches and leaves, yielding volatile monoterpenes and sesquiterpenes, with a hydrosol byproduct containing water-soluble components like linalool.
No human clinical trials, RCTs, or meta-analyses on Kuromoji have been conducted. Current research is limited to in vitro studies on cell lines and laboratory analyses of chemical composition (PMIDs: 34732636, 32933154).
No clinically studied dosage ranges exist for Kuromoji extracts, powders, or standardized forms as human trials are absent. Consult a healthcare provider before starting any new supplement.
Kuromoji (Lindera umbellata) is not consumed as a food source and therefore lacks a conventional nutritional profile (macronutrients, vitamins, minerals, fiber, protein are not applicable in dietary context). Its relevance lies entirely in its bioactive phytochemical composition, primarily concentrated in the essential oil and aqueous extracts from leaves, bark, and twigs. Key bioactive compounds include: **Terpenoids** — the essential oil is dominated by monoterpenes and sesquiterpenes, with linalool (approximately 20–45% of essential oil depending on plant part and chemotype), 1,8-cineole (eucalyptol, ~5–15%), α-terpineol (~3–8%), geraniol (~2–6%), limonene (~2–7%), β-caryophyllene (~3–10%), and germacrene D (~2–8%). **Lactones** — linderanolide and related sesquiterpene lactones have been identified in bark extracts, contributing to anti-inflammatory activity. **Flavonoids and polyphenols** — quercetin derivatives, kaempferol glycosides, and catechins are present in leaf extracts at modest concentrations (total polyphenol content of aqueous leaf extracts estimated at ~15–40 mg gallic acid equivalents per gram of dry weight, though values vary significantly by extraction method and plant part). **Alkaloids** — trace amounts of aporphine-type and benzylisoquinoline alkaloids (e.g., boldine-related compounds) are reported in Lindera species, though specific quantification in L. umbellata is limited. **Other compounds** — bornyl acetate (~1–5% of essential oil), camphor (trace to ~3%), and small amounts of fatty acids in seed oil. Bioavailability notes: Essential oil terpenoids such as linalool are rapidly absorbed transdermally and via inhalation (relevant for aromatherapy use), with moderate oral bioavailability but rapid hepatic metabolism. Polyphenolic compounds have characteristically low oral bioavailability (typically <5–10%) due to extensive first-pass metabolism and poor intestinal absorption. Sesquiterpene lactones may have improved absorption due to lipophilicity but are also subject to rapid conjugation. No standardized extract concentrations or recommended dosages have been established in pharmacopeial references. All quantitative values cited are approximate, derived from limited analytical studies, and subject to significant variation based on geographic origin, harvest season, plant part, and extraction methodology.
Kuromoji's essential oils, particularly linalool and eucalyptol, exert anti-inflammatory effects by suppressing NF-κB signaling pathways and reducing pro-inflammatory cytokine production including TNF-α and IL-6. The antitumor activity occurs through mitochondrial membrane potential disruption, leading to caspase-3 activation and apoptotic cell death. Its deodorizing properties result from volatile compounds that neutralize sulfur-containing odor molecules through chemical binding.
Current research on kuromoji is limited to in vitro and animal studies, with no human clinical trials available. Laboratory studies using LPS-stimulated macrophages showed significant reduction in inflammatory markers at concentrations of 50-100 μg/mL. Cancer cell line studies demonstrated IC50 values ranging from 25-75 μg/mL for various tumor types, indicating moderate cytotoxic potential. The evidence remains preliminary and requires human studies to establish therapeutic efficacy and optimal dosing.
Safety data for kuromoji supplementation is extremely limited due to lack of human studies. As with other Lindera species, potential allergic reactions may occur in sensitive individuals, particularly those with plant allergies. No specific drug interactions have been documented, but theoretical interactions with anticoagulant medications are possible due to essential oil content. Pregnancy and breastfeeding safety is unknown, and use should be avoided during these periods.
